CLINICAL CORNER: Medtronic’s Prestige LP Cervical Disc; Biotronik’s Orsiro DES, More
This article was originally published in Clinica
Executive Summary
Clinica’s Clinical Corner provides an update on the latest R&D news and developments in ongoing clinical trials of early-, late-stage and approved medical devices.
You may also be interested in...
Global Approvals Analysis: LivaNova, Abbott, Medtronic, Boston Scientific Lead List Of January Cardio Approvals
January brought 23 non-US approvals, including 13 CE marks, according to Medtech Insight's Approvals Tracker. The total for January 2018 also exceeds the 20 non-US approvals recorded a year ago.
Robert Byrne: Absorb, Synergy, And The Future Of Coronary Stents
One of the most controversial, and potentially impactful, questions in medical device development today is how to better prevent late events, especially late stent-thrombosis, in coronary stent patients. The two leading answers to this question are a completely bioresorbable drug-eluting stent and a metal drug-eluting stent with a bioresorbable polymer, but there may be even more ideas on the horizon. One of the leading experts in the field and a cardiologist with experience with most of these new technologies, Robert Byrne of Deutsches Herzzentrum in Munich, recently talked to Medtech Insight about the questions that still need to be answered in this field and how it can move forward.
Medtronic’s Prestige LP Joins LDR’s Mob-C In Two-Level Cervical Disc Competition
The US FDA approved Medtronic's artificial disc based on results of a 397-patient trial showing more favorable outcomes with Prestige LP than anterior cervical discectomy and fusion.